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It is well recognized that patients with classical mycosis fun-
goides (MF) may develop a large-cell lymphoma (LCL), a 
phenomenon known as "transformation." An unresolved 
issue regarding the transformation of MF is whether MF and 
LCL represent two separate lymphomas or whether they are 
derived from the same T-cell clone. We report the clinico-
pathologic, immunophenotypic, and immunogenotypic 
analysis of MF and LCL in a white male. He developed a rash 
at age 51 that was diagnosed at age 56 as clinical stage IA 
patch/plaque MF. After topical nitrogen mustard and total 
skin electron beam therapy for progressive generalized 
CD3+CD4+ patch/plaque lesions, he developed nodules of 
Ki-1+ (CD30+) T-LCL at age 72. Southern blot analysis of 
DNA digested with BgllI or BamHI and probed with aT-cell 
receptor (TCR)-{3 gene J{31/J{32 probe showed a single, iden-
tical rearranged band in both the MF and LCL skin lesions 
M ycosis fungoides (MF) is a form of cutaneous T-cell lymphoma that usually presents with flat patches or infiltrated plaques that may progress to skin tumor nodules or extracutaneous involve-ment [1). A variant of MF involving erythro-
derma and leukemia is known as the Sezary syndrome (SS) [1). 
Patch/plaque skin lesions typically contain an epidermotropic, 
band-like infiltrate of cytologically atypical lymphoid cells with 
dense, cerebriform nuclei [1). The development of a large-cell lym-
phoma (LCL) occurs in 5 - 20% of MF patients and is referred to as 
the "transformation of MF" ([1- 5). Cerroni L, Hodl S, Rieger E, 
Soyer HP, Smolle J, Ked H: Transformation of mycosis fungoides 
to large cell lymphoma (abstr).] Gutar! Patho117:290, 1990). Trans-
formation has been defined as the presence of LCL cells forming 
microscopic nodules or exceeding 25% of the totallesional infiltrate 
[1,4) . The histopathologic subtypes of LCL in transformed MF 
include "immunoblastic" and "anaplastic" variants. The transfor-
mation of MF implies a poor prognosis with a median survival of 
only 1- 2 years (ll,4) , Cerroni L, Hod I S, Rieger E, Soyer HP, 
Manuscript received October 2, 1992; accepted for publication February 
10, 1993. 
Reprint requests to: Dr. Gary S. Wood, Chief, Dermatology - lIG(W), 
VA Medical Center, 10701 East Boulevard, Cleveland, OH 44106. 
Abbreviations: EMA, epithelial membrane antigen; LCL, large ceLllym-
phoma; MF, mycosis fungoides; SS, Sezary syndrome. 
that had been obtained 4 years apart. V {3 gene family - specific 
gene amplification assays demonstrated dominant V{36 PCR 
products in both types of lesions. These PCR products and 
lesional cDNA exhibited a monoclonal pattern when ampli-
fied with consensus TCR-{3 gene VDJjoint primers and elec-
trophoresed under conditions that allowed the resolution of 
small differences in size. Furthermore, sequence analysis of 
the V{36 PCR products amplified from both the MF and LCL 
lesions showed an identical nucleotide sequence involving 
V{36.4, D{31.1, J{31.2, and C{31. These findings indicate that 
both the MF and the LCL in this patient arose from the same 
T-cell clone and that these diseases developed at a stage in the 
clone's differentiation subsequent to rearrangement of the 
TCR-{3 gene. Key words: Skin/lymphoma/molecular biol-
ogy /immunophenotyping/mycosis fungoides. ] Invest D er-
matoI101:296-300, 1993 
Smolle J, Ked H: Transformation of mycosis fungoides to large cell 
lymphoma. ] GUlar! Patho117:290, 1990). 
Most cases of MF are neoplasms of immunophenotypically ma-
ture helper T cells expressing CD4, the exp T-cell receptor (TCR) 
protein heterodimer, and the pan T-cell antigens CD2, CD3, and 
CDS. The CD7 antigen is often absent and cells expressing activa-
tion antigens such as CD30 (Ki-l) are rare [1). In contrast, patients 
who have undergone transformation often exhibit a very different 
T-cell immunophenotype within their LCL lesions, manifested as 
the absence of multiple pan T-cell antigens in most cases and ex-
pression of the CD30 (Ki-1) antigen in about 50% of cases [1) . 
Other activation antigens may also be expressed by T -cell LCL 
including CD15 (Leu-Ml), CD25 (TAC), and EMA (epithelial 
membrane antigen) [5 -10). 
Despite these clinicopathologic and immunophenotypic differ-
ences, an unresolved issue regarding the transformation of MF is 
whether the MF and LCL represent two separate T -cell lymphomas 
or whether they are derived from the same T-cell clone. We hy-
pothesized that if the MF and LCL neoplasms shared a common 
T -cell clonal ancestry and developed after rearrangement of the 
clone's TCR exp genes, then both the MF and LCL should share 
identical, dominant monoclonal TCR-P gene rearrangements. To 
test this hypothesis, we studied the clinicopathologic, immuno-
phenotypic, and immunogenotypic features of MF and subsequent 
LCL occurring in an adult white man. We employed Southern blot 
ana lysis, Vp gene family-specific gene amplification techniques, 
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Table I. Comparative Immunophenotypic Analysis of Cells 
Infiltrating the MF and LCL Skin Lesions 
Antigens 
Pan T-Cell 
CD2 (Leu-5) 
CDS (Leu-1) 
CD7 (Leu-9) 
TCR-Associated 
CD3 (Leu-4) 
p Framework (8A3) 
T-Cell Subset 
CD4 (Leu-3) 
CD8 (Leu-2) 
Activation/Other 
CD15 (Leu Ml) 
CD25 (TAC) 
CD30 (Ki-l) 
CD38 (TiO) 
CD45RB (PD7/26) 
CD45RO (UCHLl) 
CD71 (T9) 
Epithelial membrane antigen 
• ND. not done. 
1985 MF Plaque 
+ 
+ 
+ 
ND' 
+ 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
1989 LCL Tumor 
+ 
+ 
+ 
+ 
Weak + 
Weak + 
+ 
and DNA sequencing analysis to demonstrate that the LCL that 
developed in this MF patient contained the same dominant TCR-P 
gene rearrangement as his original MF. This is the first direct proof 
that MF and transformed MF skin lesions can be derived from the 
same T-cell clone. 
MATERIALS AND METHODS 
Tissues Biopsy specimens of skin obtained from a representative MF 
plaque in 1985 and a representative LCL tumor in 1989 were routinely 
processed for light microscopy. Portions of these specimens were snap fro-
zen for subsequent immunophenotypic and immunogenotypic analysis as 
described previously [11]. 
Immunophenotyping Cryostat sections were processed for immuno-
phenotypic analrsis with use of a three-stag.e. tis.sue-staining imm~noperox­
idase technique IDvolvmg monoclonal antibodies, blOtm, and aVldm as de-
scribed elsewhere (11). The panel of monoclonal antibodies employed and 
their principal reactivities are listed in Table 1. 
Southern Blot Analysis Digests of total-tissue DNA prepared with BglII 
and BamHI were analyzed according to the Southern blot hybridization 
procedure as described elsewhere [12). A 32P-radiolabeled combined JP1/JPZ 
DNA probe was utilized as a probe for the T-cell receptor (TCR) P gene. 
This probe consisted of a 550-bp (base pair) XbaI fragment OPl probe) 
derived from DNA between the JPl and Cpt regions, and a 4.3-kb EcoRI 
fragment (JPZ probe) containing the JPZ region [13]. 
Polymerase Chain Reaction (PCR) Analysis Lesional RNA was ex-
tracted from cryostat sections, reverse transcribed into cDNA, and subjected 
to 30-35 cycles of amplification as described previously (14). The down-
stream primer consisted of a consensus Cp oligonucleotide termed cpr 
(5'-TIC TGA TGG CTC AAA CAC-3') [14]. The upstream primers con-
sisted of 20 different Vp oligionucleotides whose aggregate specilicity 
allows amrlification of the VP1- VpzO gene families. The nucleotide se-
quences 0 these Vp primers have been published elsewhere [14]. Typical 
reactions contained pairs of these V p primers with subsequent repeat analysis 
of positive reactions using individual V p primers. Positive reactions were 
assessed by electrophoresis of an aliquot of PCR product through 1.5% 
regular agarose followed by ethidium bromide staining and visualization 
with ultraviolet light. Controls included primers for p-2-microglobulin as 
described previously (14). 
VOJ Joint Monoclonality Assay Primary amplification of lesional 
cDNA and secondary amplification of Vp6-Cp I PCR products was per-
formed using the nested consensus upstream primer, 3'Vp, which is fourfold 
degenerate (5'-TGT A[TC)[TC) TCT GTG CCA GCA G-3') and the 
nested consensus downstream primer, CPII (5'-CGA CCT CGG GTG 
GGA ACA C-3'), as described previously [14). After 25 - 30 cycles of ampli-
fication, aliquots of these VD J joint PCR products were electrophoresed in a 
gel composed of 3% NuSieve agarose (FMC BioProducts, Rockland, ME) 
and 1 % regular agarose, stained with ethidium bromide and visualized using 
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ultraviolet light. Under these conditions, prior studies have shown that 
polyclonal VDJ joint PCR products produce a smeared band that can be 
readily distinguished from the sharp bands produced by monoclonal VD] 
joint PCR products (14). Dilutional studies have demonstrated a sensitivity 
limit of 0.01 % clonal T cells if diluted with nonlymphoid cDNA and a limit 
of 10% clonal T cells if diluted with polyclonal T-cell cDNA [14]. 
Nucleotide Sequence Analysis Vp6-Cpr PCR products amplified from 
both MF and LCL les.lOns were cloned into M13 and randomly selected 
clones from each specimen were sequenced using the dideoxy method as 
described elsewhere [12]. 
CASE REPORT 
. The patient (WG), a 76-year-old white man, first noted erythema-
tous, scaly patc~es on his distal lower extremities at age 51. The 
cutaneous eru~t1on sp~ead to involve his buttocks and a diagnosis of 
MF was establtshed histopathologically at age 56. At that time he 
had cutaneous plaques i~ a bathing trunk distribution (clinical stage 
IA) and. was . treated With topical mtrogen mustard until age 60, 
w~en hiS skl.n cl~ared . Plaque disease recurred within 1.5 years, 
With generahzed 111volvement, and topical nitrogen mustard was 
resumed. Treatment was continued intermittently and there was a 
general progression of disease over the next several years. At age 69, 
he underwent a .course of t.otal skin electron-beam therapy (35 Gy) 
~ollow~d by adjuvant topical nitrogen mustard, which was used 
~ntermlttently. During the next 4 years, he developed tumorous 
111volvement. At age 72, l1lStopathoiogic examination of a cutane-
~us tumor demonstr~ted transformation to large-cell (immunoblas-
tic) .Iymphoma. "!,hlS was also noted in subsequent biopsies. He 
received local radiation therapy to selected sites and then, at age 75, 
underwen~ a second. course of total skin electron-beam therapy 
(24 G~). S111ce that time, h~ has continued to have progressive dis-
ease With plaques and multiple ulcerated tumors. Since age 72, he 
has also had multiple cutaneous squamous cell carcinomas involving 
the face and one involving the scrotum. 
Light. Microscopy !~e 1985 MF plaque lesion and other repre-
sentatlv.e plaques exll1~lted an epidermotropic, band-like, upper 
der~aI111filtrat.e of aty~lcallymphocytes with hyperchromatic, cer-
ebnform nucleI. The histopathologic features were those of classical 
MF. In c?ntrast, the 198~ tumor nodule and other representative 
tumors displayed a nonepldermotropic, diffuse dermal infiltrate of 
large atypicallympho~ytes with large nuclei containing prominent 
nucleoh. Abno~mallrutotl~ figures were readily identified and epi-
dermal ulceration was vanably present. The histopathologic fea-
tures were those of the Immunoblastic variant of large-cell lym-
phoma. Only rare cells (about 1%) had the cytologic features of 
anaplastic large cell lymphoma. 
RESULTS 
Immunoph.enotyping Immu.nohistologic analysis of the MF 
and LCL leSIOns IS summanzed 111 Table 1. Although both lesions 
were clearly ofT-cell differentiation, the LCL tumor was a CD30+ 
im~unoblastic T-cell lymphoma that expressed several activation 
antigens but lac~ed several T-cell antigens in comparison to the MF 
plaque. In !ddltl.on, the LCL lesion was o~y weakly CD45RB+ and 
CD45RO . ThiS contrasts With the typically strong expression of 
CD~5, CD4.5RB, and CD45RO 111 patch/plaque MF [15] but is 
conS1S~ent With the weak or absent expression of CD45 among a 
m1110nty ofLCLs [7,8,10]. Nevertheless, retained expression of the 
TCR-associated antige~ls CD3 and TCR-P framework (8A3) sug-
gested that the LCL leSIOn possessed a functional TCR-P gene rear-
rangement. Although 8A3 expression was not assessed for the MF 
plaque, the knowledge that virtually all such cases are 8A3+ [16] and 
the demonstratl?n of the TCR-associated CD3 antigen suggested 
that the MF leSIOn also possessed a functional TCR-P gene rear-
rangement. 
Southern Blot Analysis Comparative studies of the MF and 
LC~ lesion~ up to this point had revealed major clinical, histopatho-
logiC, and Immullophenotypic differences. Nevertheless, the im-
munophenotypic studies also suggested that both MF and LCL 
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Figure 1. Southern Blot analysis of TCR-P gene rearrangements. Paired 
BglII digests of lesional genomic DNA probed with a combined JP1/JP2 
radiolabeled DNA probe. Both the 1985 MF specimen (left) and the 1989 
LCL specimen (right) contain an identical rearranged band (arrowhead). 
specimens contained rearranged TCR-fJ genes . To confirm this and 
to perform comparative studies of these rearrangements, lesional 
genomic DNA extracted from representative MF and LCL speci-
mens was digested separately with BgllI and BamHI and subjected to 
Southern blot analysis using a combined JfJl/JfJ2 TCR probe. In 
each type of digest, a single rearranged band that was identical in 
size for both the MF and LCL samples was detected. The BglII 
digest is illustrated in Fig 1. These results provided strong evidence 
that the MF and LCL lesional infiltrates were derived from a com-
mon T-cell clone. 
Evaluation of VfJ Gene Expression To confirm the implica-
tions of the Southern blot analyses, cD NA prepared from both MF 
and LCL biopsies was amplified for 30 cycles with pairs of 5' VfJ 
specific primers in conjunction with a 3' CfJ primer (CfJI) . The VfJ 
primer set was desi gned to amplify genes from 20 different VfJ 
families. Any resultant PCR products were detected by visual in-
spection following electrophoresis and staining with ethidium bro-
mide. As shown in Fig 2 for the 1985 biopsy, only the reaction 
containing the VfJ6 primers generated substantial levels of products 
(lane 4), which on subsequent analysis (not shown) proved to be due 
to the Vp6 primer. Similar PCR results suggesting that a majority of 
T cells expressed an antigen-receptor gene from the VfJ6 family 
PCR PRIMERS 
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Figure 2. PCR analysis of Vp expression. cDNA prepared from the 1985 
MF skin biopsy was amplified with pairs of different 5' V P specific primers, 
as indicated, and a 3' Cp primer (CfJI). Shown are the resultant vp PCR 
products as well as P2 microglobulin control PCR products (p2m) following 
electrophoresis in 1.5% agarose and staining with ethidium bromide. Subse-
quent PCR analysis indicated that only the VP6 primer was required to 
generate the band in latle 4. 
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Figure 3. VD] joint clonality analysis. Shown arc PCR products generated 
using the nested consensus VD] joint primers (3'VP and CfJII) following 
electrophoresis in 3% N uSieve - 1 % regular agarose and staining with ethi-
dium bromide. Templates for the PCR reactions were cON A from the 1985 
MF (1) and 1989 LCL (2) biopsies (la/l es 1 alJd 2) or PCR products generated 
by amplification of cDNA from biopsy 1 or normal blood lymphocytes 
(Ialles 3 atld 4) with the V P6-CfJI primers. The positions assumed by molecu-
lar-weight markers are also shown. 
were also obtained from the 1989 biopsy (not shown). In contrast, 
all of the Vp primers produced easily visualized products of the 
appropriate size when cDNA prepared from normal donor periph-
eral blood lymphocytes was amplified under similar conditions (not 
shown). 
VDJ Monoclonality Assay To help establish that the VfJ6 signal 
came from the MF cells, biopsy cD N A as well as the V P6-CfJI PCR 
products were amplified with nested consensus VDJ joint primers 
(3'VP and CfJII) and the resultant products were electrophoresed 
under conditions that permitted resolution of small differences in 
size. With this technique, monoclonal T ce lls generate sharp bands 
because all have the same-sized j oint, w hereas polyclonal T cells 
produce smears due to variations in joint length of 10 - 30 nucleo-
tides, which are typically present. As shown in Fig 3, single sharp 
bands were generated from cDNAs prepared from both biopsies, 
suggesting that the same monoclonal T-cell population was present 
in both specimens (lanes 1 and 2) . Joint primer amplification of 
PCR products generated with the VP6-CfJI primers also gave sharp 
bands, indicating that they were indeed monoclonal (lane 3). As 
would be expected if a single clonal T-cell population was present in 
both biopsies, all of the bands generated with the joint primers were 
found to co-migrate. In contrast to these results,joint primer ampli-
fication followed by electrophoresis and ethidium bromide staining 
of control polyclonal templates gave smears under these conditions, 
as shown for PCR products produced from normal donor peripheral 
blood lymphocyte cDNA with the VP6-CfJI primers (lane 4). 
Nucleotide Sequence Analysis To verify further that both 
biopsies contained identical monoclonal T-cell populations, the 
V P6-CfJI PCR products amplified from both biopsies were cloned 
into M13 and four randomly selected clones from each biopsy were 
sequenced. With one exception, all of the sequences were identical 
and showed a functional V p gene that was generated by a productive 
rearrangement of the V P6.4, DP1.1, and JP1.2 germline gene seg-
ments (Fig 4). The exceptional sequence mentioned above, which 
was most likely introduced because of a polymerase error during 
amplification, differed by only a sing le nucleotide substitution from 
the others. 
DISCUSSION 
In this study of a patient who underwent transformation of MF, we 
have shown that the MF and LCL lesions were derived from the 
same T-cell clone. This clone contained a functiona l TCR-P gene 
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VJl6 . 4 
R pE G S v S T L T I Q R T E Q R D S AM 
AGGCCTGAGGGATCCGTCTCCACTCTGACGATCCAGCGCACAGAGCAGCGGGACTCGGCCATG 
I n DJll n I y RCA S S L G P F G Q G Y G Y T F G TATCGCTGTGCCAGC AGC TTAGGTCCCTTT GGACAGGG T TATGGCTACACCTTCGGT 
JJll . 2 I CJll 
5 G T R LTV V E D L N K V F P P E V 
TCGGGGACCAGGTTAACCGTTGTA GAGGACCTGAAC AAGGTGTTCCCACCCGAGGTCG 
F· re 4. Nucleotide sequence of cloned TCR-/1 gene rearrangements. p~~ products from both biopsies generated by amplification with the V/16-
Cpr primers were cloned into M 13. This sequence was obtallled from all four 
lones analyzed from each biopsy with the exception that one clone had a 
c. gle nucleotide substitution. This TCR-/1 gene rearrangement contallls the 
Slll . I I·d d V /16.4, J/11.2, and C/11 segments, as indicated, along Wit 1 N nuc eot! . es an 
D segment (nDn). The sequences of ~he prin~ers used for ampitficatlOn are 
underlined. The single letter ammo aCid code IS also shown. 
rearrangement involving VP6.4, DP1.1, and JP1.2. Southern blot 
analysis demonstrated that a single dominant T-cell clone was 
present in each lesion and provided evidence that these clone~ w.ere 
the same because their TCR-P gene rearrangement was of similar 
size following digestion with BglII or BamHI restricti~n endonu-
cleases. Using Vp gene family -specific PCR methods, It was the? 
shown that Vp6 PCR products were the dominant products al~lph­
fiable from both types of lesions. These PCR products and leslOnal 
cDNA exhibited a monoclonal pattern when amplified with con-
sensuS VD] joint primers (3'VP and CPU) and elec~rophores~d 
under conditions that allowed the resolution of smal~ differences. In 
size. Finally, the Vp6 PCR products showed an identical nucleotide 
sequence in both the original MF and subsequent LCL leSions. I.n 
this particular case, the LCL that developed had the morl?hologlc 
features of the "immunoblastic" rather than the "anaplastic" LCL 
subtype. Consistent with this was its EMA- phenotype [7 -9]. TIllS 
serves to emphasize that not all cutaneous CD30+ LCL are CD30+ 
anaplastic LCL. . . 
Although some elegan~ studies have been ~ubhshedus111g tumor 
~ clone-specific PCR techruques to study the dissemination of ~F or 
SS within individual patient tissues [17,18], our current study IS the 
fust PCR-based analysis to unequivocally demonstrate t.he clo~al 
identity between MF and LCL lesions arising in a patient With 
transformation of MF. Perhaps the most relevant related work 111-
volves a recent report in which molecular biologic techniques were 
used to study the T-cell clonality of a patient with MF.who then 
sequentially developed Hodgkin's disease, lymphomatOid papulo-
sis, erythrodermic MF with circulating tumor cells (p~esumed ~S~, 
and finally underwent transformation to LCL [19] . US111g SOphiSti-
cated T-cell-clone-specific PCR techniques, it was shown that a 
clonal TCR-a gene rearrrangement, identified in cell lines estab-
lished from a LCL lesion, was also present in the earlier lesions of 
Hodgkin's disease and lymphomatoid papulosis. However, bec~use 
the PCR assay was specific for a single clone, it provided no direct 
proof that the clone ?etected .was the dominant (t~mor-relevant) 
clone in any of the leSIOns studied. TIllS IS a general pitfall of studies 
involving tumor-clone-specific PCR assays. It is particularly rele-
vant to studies of MF because we have shown recently that MF 
tumor cells can be detected in concurrent non-MF lymphoid lesions 
such as all ergic contact dermatitis (Veelken H, Sklar ], Wood G: 
Presence of malignant T -cells in lesions of allergic contact dermati-
tis developing in patients with cutaneous T-cell lymphoma (abstr). 
111II1Iunobioiogy 186:152, 1992). Furthermore, th~ ,!,CR~a-based 
study presented no clone-specific PCR data perta111111g directly to 
the relationship between the MF and LCL skin lesions. In contr~st, 
this is the focus of our current report concerning the transformatIOn 
ofMF. 
The phenomenon of transformation to a more clinically aggres-
sive form of lymphoma or leukemia is not unique to MF. Other 
types of peripheral T-cell lymphomas, including small-cell an.d 
Iymphoepithelial variants, may transform to LCL [9]. Appro.xl-
mately 25% offollicular B-ceillymphomas undergo transformatIOn 
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Figure 5. One- and rwo-clone models for the origin ofLCL in MF patients 
undergoing transformation. 
to diffuse LCL or occasionally to acute lymphoblastic leukemia 
(ALL) [20] . Transformation to LCL occurs in about 10% of patients 
with B-cell chronic lymphocytic leukemia (B-CLL) and is known 
as Richter's syndrome [21]. A similar process is the development of 
"blast crisis" in patients with chronic myelogenous leukemia 
(CML) [22]. Using a variety of molecular biologic, anti-idiotype 
monoclonal antibody, and isoenzyme analyses, it has been shown 
for follicular lymphomas [20], Richter's syndrome [21,23] , and 
CML [22] that the transformed tumor shares the same clonal origin 
as the original neoplasm. 
The results of our study indicate that MF and transformed MF are 
also derived from a single T-cell clone. A two-clone model of the 
transformation of MF is excluded by the finding of identical TCR-P 
gene rearrangements in the MF and LCL lesions (see Fig 5). This 
finding also suggests that the genetic events leading to MF and LCL 
in this patient occurred at the cortical-thymocyte stage of differen-
tiation, or later, rather than in a stem cel l that might have given rise 
to two different T-cell clones bearing distinct TCR-P gene rear-
rangements [10] . 
The one-clone model depicted in Fig 5 hypothesizes the sequen-
tial progression from a premalignant T cell to MF to LCL. Another 
possibility is that the MF and LCL arise independently from differ-
ent progeny of the same premalignant T-cell clone. This form of 
parallel, as opposed to serial, disease evolution would still be com-
patible with our data. However, we favor the serial model because 
transformed cells often exist intermingled with typical MF tumor 
cells in lesional biopsy specimens [4]. Furthermore, studies of the 
transformation of follicular B-cell lymphoma to ALL have docu-
mented the sequential acquisition of genetic abnormalities such as 
t{14;18) and t(8;14) chromosomal translocations [20]. These find-
ings suggest that transformation occurs when a second somatic mu-
tational event, or series of events, confers a proliferative advantage 
to a subclon~?f the original neoplastic clone. It will be important to 
analyze additional cases of transformed MF to determine if they too 
will show the same clonal origin as the original MF lesion. 
Supported by Merit Review jrltldilJgjrolll ti,e DcpartlllelJt ojVetera lJs Affa irs (Dr. 
Wood) alJd by NIH gralJcs AR40844 (Dr. Wood) alJd CA34233 (Dr. Levy). 
REFERENCES 
1. Wood GS: The benign and malignant cutaneous lymphoprol iferative disorders 
including mycosis fungoides. In: Knowles OM (cd.). Neoplastic Hematopath-
ology, 1st cd. Williams and Wilkins, Baltimore, MD, 1992, pp 919-930 
2. Sausville EA, Eddy JL, Makuch R W, cl al: Histopathologic staging at initial 
diagnosis of mycosis fungo ides and the Sezary syndrome: definition of three 
distinctive prognostic groups. A m, [Ill Med 109:372 - 382, 1988 
3. Dmitrovsky E, Matthews MJ, Bunn PA, el al: Cytologic transformation cutane-
300 WOOD EY AL 
ous T -cell lymphoma: a clinicopathologic entity associated with poor progno-
sis.] eli" Ollcol 5:208 - 215, 1987 
4. Salhany!{E, Cousar JB, Greer JP, Casey TT, FieldsJP, Collins RD: Transforma-
tion of cutaneous T -cell lymphoma to large cell lymphoma: a clinicopathologic 
and immunologic study. Alii] Patllo/132:265 -277, 1988 
5. Wieczorek R, Suhrland M, Ramsay 0, Reed ML, Knowles OM: Leu-M! antigen 
expression in advanced (tumor) stage mycosis fungoides. Alii] eli" Potllol 
86:25 -32,1986 
6. Wieczorek R, Burke JS, Knowles OM: Leu-MI antigen expression in T-cell 
neoplasia. Am] PathoI121 :374-380, 1985 
7. Suchi T, Lennert K, Tu L-Y, Kikuchi M, Sato E, Stansfeld AG, Feller AC: 
Histopathology and immunohistochemistry of peripheral T cell lymphomas: a 
proposal for their classification.] elill Patllol 40:995 -1015, 1987 
8. Kadin ME: Hodgkin's disease: immunobiology and pathogenesis. In: Neoplastic 
Hematopathology, 1st ed. In: Knowles OM, (ed.). Williams and Wilkins, 
Baltimore, MD, 1992, pp 540-541 
9. Pinkus GS, Said JW: Peripheral T-cell Lymphomas. In: Knowles OM (ed.) . 
Neoplastic Hematopathology, 1st ed. Williams and Wilkins, Baltimore, MD, 
1992, pp 837 - 867 
10. Knowles OM, Chadburn A, Inghirami G: Immunophenotypic markers useful in 
the diagnosis and classification of hematopoietic neoplasms. In: Knowles OM, 
(ed .). Neoplastic Hematopathology, 1st ed. Williams and Wilkins, Baltimore 
MD,1992, pp73 - 167 
II. Wood GS, Warnke R: The immunophenotyping of bone marrow biopsies and 
aspirates: frozen section techniques. Blood 59:913 - 922, 1982 
12. SambrookJ, Fritsch EF, Maniatis T: Molecular Cloning; A Laboratory Manual, 
2nd cd. Cold Spring Harbor Press, Cold Spring Harbor, New York, 1989 
13. WoodGS, Weiss LM, Hu C-H, Abel EA, Hoppe RT, Warnke RA,SklarJ:T-cell 
antigen deficiencies and clonal T-cell receptor gene rearrangements in pagetoid 
reticulosis (Woringer-Kolopp disease). N Engl] Med 318:164 -167, 1988 
14. Bahler OW, Berry G, OksenbergJ, Warnke R, Levy R: Diversity T-cell antigen 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
receptor variable genes used by mycosis fungoides cells. Am] PatIIOI140:1-8, 
1992 
IS. Wood GS, Dubiel C, Mueller C, Abel EA, Hoppe RT, Edinger A, Weissman I, 
Warnke RA: Most CD8+ cells in skin lesions of CD3+CD4+ mycosis fungoides 
are CD3+Tcells that lack COl1b, COI6, C056, CD57 and human Hanukah 
factor mRNA. Am] PatlloI138:1545-1552, 1991 
16. Michie SA,Abel EA, Hoppe RT,PickerLJ, Warnke RA, Wood GS: Expression of 
T-cell receptor antigens in mycosis fungoides and inflammatory skin lesions. 
] I"vest DerlllatoI93:116-120, 1989 
17. Lessin SR, Rook AH, Rovera G: Molecular diagnosis of cutaneous T-celllym-
phoma: polymerase chain reaction amplification of T-cell antigen receptor 
p-chain gene rearrangements.] III vest Dcrlllatol96:299 - 302, 1991 
18. Volkenandt M, Soyer HP, Ked H, Bertino JR: Development of a highly specific 
and sensitive molecular probe for detection of cutaneous lymphoma.] I"vest 
Dermatol97:137 -140, 1991 
19. Davis TH, Morton CC, Miller-Cassman R, Balk SP, Kadin ME: Hodgkin's 
disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived 
from a common T-cell clone. N Ellgl] Med 326:1115-1122,1992 
20. Harris NL, Ferry JA: Follicular Lymphoma and Related Disorders (Corminal 
Center Lymphomas). In: Knowles OM (cd.). Neoplastic Hematopathology, 1st 
cd. Williams and Wilkins, Baltimore, MD, 1992, PP 651-654 
21. Foucar K: B Cell Chronic lymphocytic leukemia and prolymphocytic leukemia. 
In: Knowles OM (cd.). Neoplastic Hematopathology, 1st cd. WillianlS and 
Wilkins, Baltimore, MO, 1992, P 1196 
22. VardimanJW: Chronic Myelogenous Leukemia and the Myeloproliferative Dis-
orders. In: Knowles OM (ed.). Neoplastic Hematopathology, 1st cd. WillianlS 
and Wilkins, Baltimore, MD, 1992, pp 1407-1415 
23. Bertoli LF, Kubagawa H, Borzillo GV, Mayumi M, Prchal JT, Kearney JF, 
Durant JR, Cooper MD: Analysis with antiidiotype antibody of a patient with 
chronic lymphocytic leukemia and a large cell lymphoma (Richter'S syn-
drome). Blood 70:45 - 50, 1987 
ANNOUNCEMENT 
The Second Congress of the European Society of Contact Dermatitis will be held in Barcelona, 
Spain, 6-8. October 1994. The President is Dr. Agustin Alomar Muntanola. The Organizing 
Secretary IS Grupo Geyseco, c/Muntaner, 77 bajos, Barcelona 08011, Spain. Phone: 
34.3.453.92.89/451.08.86; Fax: 34.3.453.24.94. 
